{"id":"W4366446437","doi":"10.1200/jco.23.00294","title":"Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Guideline Update","year":2023,"lang":"en","type":"review","venue":"Journal of Clinical Oncology","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":317,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Apixaban; Medicine; Rivaroxaban; Guideline; Randomized controlled trial; Venous thromboembolism; Intensive care medicine; Perioperative; Cochrane Library; Dabigatran; MEDLINE; Surgery; Internal medicine; Warfarin; Thrombosis","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002072049,0.0004650359,0.01067849,0.0003671552,0.00004671558,0.00001758806,0.0002170004,0.0007225571,0.00008050849],"category_scores_gemma":[0.0006239842,0.0002582239,0.0007516124,0.0003566241,0.0001993261,0.00007386322,0.0001264494,0.001120927,0.00003565764],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007223689,"about_ca_system_score_gemma":0.00336962,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002902976,"about_ca_topic_score_gemma":0.0003559941,"domain_scores_codex":[0.9934279,0.000477801,0.004731417,0.0004539902,0.0005031244,0.0004057162],"domain_scores_gemma":[0.9944422,0.0007989442,0.003600226,0.0003506815,0.0003916555,0.0004162726],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003472244,0.006356759,0.002317764,0.002028557,0.002551953,0.0007783965,0.00004081801,0.000003428529,3.877457e-9,0.00003171323,0.004654109,0.9808893],"study_design_scores_gemma":[0.006204598,0.03444319,0.05081862,0.007405361,0.00551204,0.00003819809,0.00001521298,0.000001396744,2.566115e-8,0.00003499331,0.895317,0.0002093429],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.01371289,0.9807306,0.000002764727,0.001262303,0.001626942,0.002196503,0.00004613542,0.00002050223,0.0004013633],"genre_scores_gemma":[0.0002313928,0.9967549,0.000714565,0.0006110496,0.001332105,0.00008745944,0.00004486143,0.0000883401,0.00013534],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9806799,"threshold_uncertainty_score":0.999987,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1395609783394468,"score_gpt":0.4843872588091861,"score_spread":0.3448262804697393,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}